Abstract

Obesity is associated with a prothrombotic milieu and an increased risk for thrombotic events. Bariatric surgery is the most effective treatment for obesity resulting in dramatic weight loss and reduced inflammation and extrinsic coagulation pathway activation. Blood samples were drawn from 60 patients undergoing Roux-en-Y gastric bypass surgery before and 1 year after the intervention. Protein C (PC), activated PC (APC), soluble thrombomodulin (TM), soluble E-selectin (E-Sel), prothrombin time (PT) and activated partial thromboplastin time (aPTT) were evaluated. Both PC (187.4 ± 64.5% before surgery to 118.1 ± 48% 1 year after surgery, p < 0.001) and APC (138.7 ± 64.4% before surgery to 69.1 ± 65.7% after surgery, p < 0.001) were reduced following surgical intervention. TM showed a similar behavior with a reduction of soluble TM after the procedure from 5.7 ± 2.6 to 3.2 ± 1.4 ng/ml (p < 0.001). Similarly, soluble E-Sel was reduced after surgery from 26.6 ± 12.7 to 5.5 ± 4.1 ng/ml (p < 0.001). In contrast, aPTT was not shortened but slightly increased from 29.1 ± 4.8 s. before surgery to 31 ± 4.4 s. (p = 0.001) after surgery and levels of PT were reduced after surgery to 89.6 ± 15.5% from an initial 97.5 ± 13.5% (p < 0.001). In conclusion, we demonstrate a reduction of PC and APC 1 year after bariatric surgery accompanied by a reduction in soluble TM and soluble E-Sel. The reduction of PC and APC is not paralleled by a reduction but in contrast by a prolongation of aPTT suggesting a compensatory upregulation of PC during obesity. The reduction of TM and E-Sel might hint towards an improved endothelial function in this cohort of patients.

Highlights

  • Obesity as a major health problem worldwide is rising with a yearly mean body mass index (BMI) increase of 0.4–0.5 kg/m2 [1]

  • We studied changes in coagulatory parameters in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery

  • Several parameters determined in our patient cohort were comparable to already established results from bariatric surgery patients including a massive drop of BMI, change in lipid profile including a drop in LDL and an increase in HDL and a reduction in inflammatory markers IL-6 and CRP and the prothrombotic protein plasminogen activator inhibitor-1 (PAI-1) [20, 21]

Read more

Summary

Introduction

Obesity as a major health problem worldwide is rising with a yearly mean body mass index (BMI) increase of 0.4–0.5 kg/m2 [1]. Obesity causes an increase in proinflammatory cytokines and premature aging [2, 3]. Obese patients show changes in their procoagulant state including increased risk of venous and arterial thromboembolism and hypercoagulability after injury [4,5,6,7]. Guideline recommendations for morbidly obese patients include bariatric surgery after failure of weight loss in a structured conservative program for patients starting at a BMI > 40 or 35 kg/m2 with secondary disease [9]. Bariatric surgery leads to a massive weight loss including obesity related changes in inflammation and coagulation

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call